2024

June 13, 2024

Change of Company Secretary

June 12, 2024

Midkine Antibody Licensing Deal

May 20, 2024

Response to Appendix 3Y Query

May 16, 2024

Change of Director’s Interest Notices

April 29, 2024

Quarterly Activities_Appendix 4C Cash Flow Report

April 29, 2024

Change in substantial holding – HNG

April 29, 2024

Notification regarding unquoted securities – AN1

April 29, 2024

Cleansing Notice

April 29, 2024

Application for quotation of securities